| abstract |
"medicament, comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders". The present invention relates to a medicine comprising at least one reducing alkyl-sugar monomer of which a hydroxyl function is replaced by an alkoxy radical in C 2 -C 40 , this medicine is advantageously intended to regulate the mechanisms inflammatory. the reducing sugar is advantageously chosen from the group consisting of rhamnose, fucose and glucose. it also relates to a method of cosmetic treatment by topically applying a composition comprising at least one reducing alkyl sugar monomer, of which a hydroxyl function is replaced by an alkoxy radical at C2-C-40. |